Impact of Hypnosis During Invasive Procedure in Intensive Care Unit (HYPNOICU)

Pain during ICU stay remains one of the major complaints for patients. Beside pain intensity, well described by patients' self reports, pain distress, which is an emotional experience, cannot be treated with usual analgesia. The aim of the study is to analyze the impact of hypnosis on pain intensity and distress on short and long term outcomes in non-sedated ICU patients.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Anticipated)

124

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Paris, France
        • Recruiting
        • Hôpital Saint-Louis
        • Contact:
          • Virginie Lemiale
          • Phone Number: +331 42 49 94 19

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Adult patients aged 18 years and older
  • ICU hospitalisation
  • Non-sedated patients who need an invasive procedure (Invasive procedures are defined as chest tube (insert or remove), fibroscopy, catheter insert, lumbar punction and bone marrow aspiration)
  • Physician experienced in hypnosis available
  • written informed consent
  • health insurance

Exclusion Criteria:

  • sedation and intubation, delirium, end-of-life decision,
  • deaf patient,
  • patient who does not understand French language,
  • pregnancy
  • patient under guardianship or curatorship
  • lack of health insurance

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Patients who receive hypnosis
Patients who receive hypnosis during procedure by experiment physician
Patients who receive hypnosis
No Intervention: Control arm
Patient with conventional pain management

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain distress
Time Frame: within the before and the first hour after the procedure

Pain distress change in the hypnosis group measured before and within the first hour after the procedure.

Pain distress will be assessed using Numeric rating scale, which goes from 0 (no pain stress) to 10 (maximum pain stress).

within the before and the first hour after the procedure

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain intensity
Time Frame: within first hour and first 24 hours after procedure
Pain intensity will be assessed using Numeric rating scale, which goes from 0 (no pain) to 10 (maximum pain imaginable).
within first hour and first 24 hours after procedure
Number of adverse events
Time Frame: during procedure
during procedure
Length of each painful procedure
Time Frame: up to 3 months
up to 3 months
Analgesia dose
Time Frame: within first and 24 hours after procedure
The dose of each analgesia treatment received by the patient will be collected.
within first and 24 hours after procedure
Type of analgesia
Time Frame: within first and 24 hours after procedure
The type of each analgesia treatment received by the patient will be collected.
within first and 24 hours after procedure
Anxiety
Time Frame: within first and 24 hours after procedure
Anxiety within first and 24 hours after procedure will be assessed using Numeric rating scale, which goes from 0 (no anxiety) to 10 (maximum anxiety imaginable).
within first and 24 hours after procedure
Hospital Anxiety and Depression scale
Time Frame: at 3 months

The HAD scale is a self-assessment scale for detecting states of depression and anxiety in the setting of an hospital medical outpatient clinic.

HADS is a self-administered scale of 14 items which assessed levels of depression and anxiety, divided into 2 subscales of 7 items (Anxiety or HADS-A, Depression or HADS-D). Each item is scored on a scale of 0 to 3. A score is generated for each of the two sub-scales (sum of the 7 items, ranging from 0 to 21). A higher score indicates worse outcome.

at 3 months
Post traumatic stress disorder assessed using Impact of Event Scale Revisited (IES R)
Time Frame: at 3 months
The IES-R is a 22-item self-report measure (for DSM-IV) that assesses subjective distress caused by traumatic events. Items are rated on a 5-point scale ranging from 0 to 4 . The IES-R yields a total score (ranging from 0 to 88)
at 3 months
Proportion of patients who had hypnosis transe
Time Frame: during procedure
during procedure
Description of the experience of hypnosis
Time Frame: at 3 months
Qualitative analysis of the experience of hypnosis will be performed using the semi-structured interview
at 3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 28, 2020

Primary Completion (Anticipated)

September 28, 2021

Study Completion (Anticipated)

December 18, 2021

Study Registration Dates

First Submitted

April 29, 2020

First Submitted That Met QC Criteria

May 19, 2020

First Posted (Actual)

May 22, 2020

Study Record Updates

Last Update Posted (Actual)

June 24, 2021

Last Update Submitted That Met QC Criteria

June 23, 2021

Last Verified

June 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • APHP191042

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain

Clinical Trials on Hypnosis group

3
Subscribe